• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Investig . Diagnostic prediction of COVID-19 based on clinical and radiological findings in a relatively low COVID-19 prevalence area

tetano

Editor, Senior Moderator
Respir Investig


. 2021 Mar 29;S2212-5345(21)00045-9.
doi: 10.1016/j.resinv.2021.03.002. Online ahead of print.
Diagnostic prediction of COVID-19 based on clinical and radiological findings in a relatively low COVID-19 prevalence area


Yosuke Amano[SUP] 1 [/SUP], Hidenori Kage[SUP] 2 [/SUP], Goh Tanaka[SUP] 2 [/SUP], Wataru Gonoi[SUP] 3 [/SUP], Yudai Nakai[SUP] 3 [/SUP], Ryo Kurokawa[SUP] 3 [/SUP], Shohei Inui[SUP] 3 [/SUP], Koh Okamoto[SUP] 4 [/SUP], Sohei Harada[SUP] 5 [/SUP], Masato Iwabu[SUP] 6 [/SUP], Yutaka Morizaki[SUP] 7 [/SUP], Osamu Abe[SUP] 3 [/SUP], Kyoji Moriya[SUP] 8 [/SUP], Takahide Nagase[SUP] 2 [/SUP]



Affiliations

Abstract

Background: Distinguishing coronavirus disease 2019 (COVID-19) pneumonia from other lung diseases is often difficult, especially in a highly comorbid patient population in a low prevalence region. We aimed to distinguish clinical data and computed tomography (CT) images between COVID-19 and other lung diseases in an advanced care hospital.
Methods: We assessed clinical characteristics, laboratory data, and chest CT images of patients with COVID-19 and non-COVID-19 patients who were suspected of having COVID-19 between February 20 and May 21, 2020, at the University of Tokyo Hospital.
Results: Typical appearance for COVID-19 on CT images were found in 24 of 29 COVID-19 cases and 21 of 168 non-COVID-19 cases, according to the Radiological Society of North America Expert Consensus Statement (for predicting COVID-19, sensitivity 0.828, specificity 0.875, positive predictive value 0.533, negative predictive value 0.967). When we focused on cases with typical CT images, loss of taste or smell, and close contact with COVID-19 patients were exclusive characteristics for the COVID-19 cases. Among laboratory data, high fibrinogen (P < 0.01) and low white blood cell count (P < 0.01) were good predictors for COVID-19 with typical CT images in multivariate analysis.
Conclusions: In a relatively low prevalence region, CT screening has high sensitivity to COVID-19 in patients with suspected symptoms. When chest CT findings are typical for COVID-19, close contact, loss of taste or smell, lower white blood cell count, and higher fibrinogen are good predictors for COVID-19.

Keywords: COVID-19; Fibrinogen; Interstitial lung diseases; Taste disorder; White blood cell count.
 
Back
Top Bottom